9/27/26
PT Maja Agung Latexindo Tbk (SURI.JK) Thesis Concerns over rising competition and potential margin compression are overshadowing recent contract wins, leading to a more cautious outlook among investors.
What Moves the Stock 01 Changes in healthcare regulations impacting supply chain dynamics 02 Fluctuations in raw material prices, particularly latex and chemicals 03 Demand shifts in the Southeast Asian healthcare market 04 Currency exchange rate movements affecting export revenues 05 Latex gloves - 60% 06 Surgical supplies - 25% 07 Other medical products - 15% 08 Sustainable medical supply production 47.5 61 75 89 103 81.00 SURI.JK Daily 81.00 Apr '26 Jun '26 Aug '26 Sep '26
My Notes "Management noted, 'While we are securing contracts, we must remain vigilant against increasing competitive pressures.'" Moat: Maja Agung has a moderate moat due to its established relationships and low-cost production capabilities… value - Investors may be drawn to the stock for its low valuation metrics relative to peers, despite current operational challenges. Interest rates have minimal direct impact on Maja Agung's business model, as it operates with zero debt. Watch on earnings: Latex price index, Healthcare spending growth in Southeast Asia, Gross margin trends. One Sentence Summary: PT Maja Agung Latexindo Tbk: the story is balanced — changes in healthcare regulations impacting supply chain dynamics.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.
